Optimind Pharma Corp.

    Optimind Pharma Corp.

    CCSE:OMND
    - -
    CAD
    - -
    - -
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    2026 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -0.04
    -0.01
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    -0.01
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    0.01
    - -
    - -
    - -
    - -
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Basic Weighted Avg Shares
    - -
    82
    100
    111
    - -
    104
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    -702.86
    -623.68
    -182.32
    -56.01
    -56.01
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    -3
    -1
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -1,809.57
    -1,136.63
    -182.32
    -97.23
    -97.23
    Working Capital
    1
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    3
    1
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -167.32
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Aug'26
    Nov'26
    Feb'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    103
    103
    103
    Market Capitalization
    1
    1
    - -

    Working Capital

    CAD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    149.86%
    Free Cash Flow
    - -
    - -
    -107.26%
    Net Income, GAAP
    - -
    - -
    -45.35%
    Sales/Revenue/Turnover
    - -
    - -
    2.47%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    -0.01
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT